Day: August 5, 2020

Reorganizing to focus on two market verticals – Healthcare and IndustrialRestructuring to reduce operating costs by $100 million per yearROCK HILL, S.C., Aug. 05, 2020 (GLOBE NEWSWIRE) — 3D Systems (NYSE:DDD) today announced a new strategic focus to accelerate the adoption of additive manufacturing solutions for applications in growing markets that demand high reliability products. “We have a tremendous opportunity in this industry, and I’m excited by the passion, the breadth of technology and the exceptional capabilities within our company,” said 3D Systems President and CEO, Dr. Jeffery Graves. “In the two months since I joined 3D Systems, I have held many reviews and discussions with our employees and key customers to understand the value we deliver, and the markets that we serve. This has enabled us to state a clear purpose...

RUTLAND, Vermont, Aug. 05, 2020 (GLOBE NEWSWIRE) — Casella Waste Systems, Inc. (“Casella”) (NASDAQ:CWST), a regional solid waste, recycling and resource management services company, today announced that it has resumed the previously announced offering of up to $40.0 million aggregate principal amount of New York State Environmental Facilities Corporation (the “Issuer”) Solid Waste Disposal Revenue Bonds (Casella Waste Systems, Inc. Project) Series 2020R-1 (the “Bonds”) to be issued under an indenture between the Issuer and the bond trustee (the “Indenture”).  The consummation of the previously announced offering of the Bonds was delayed from the originally anticipated issuance date of March 26, 2020 due to market conditions in the bond market related to the COVID-19 pandemic.The Bonds will be guaranteed under a Guaranty (the “Guaranty”)...

HOLLYWOOD, Aug. 05, 2020 (GLOBE NEWSWIRE) — NV5 Global, Inc. (Nasdaq: NVEE) (“NV5” or the “Company”), a provider of professional and technical engineering, geospatial, and consulting solutions, today reported financial results for the second quarter ended June 27, 2020.In the second quarter, Gross Revenues increased 27% and Gross Revenues, exclusive of sub-consultant services and other direct costs (“Net Revenues”), increased 29%. “We are pleased with our second quarter performance, which exceeded analyst expectations in both gross revenues and adjusted earnings per share, while generating strong cash flows from operations and adjusted EBITDA, despite the impacts of the COVID-19 pandemic. We also secured a number of large contracts with utilities, departments of transportation, and the municipal...

LOS GATOS, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) — Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and intellectual property licensing company focused on deploying its proprietary technology into the semiconductor industry, today provided a corporate update and announced financial results for the second quarter ended June 30, 2020.Company HighlightsGrew to a record 17 customer engagements in Phase 3Validated Atomera’s breakthrough MST-SP results on customer siliconCompleted $10 million public offering of common stockManagement Commentary“We are very pleased to continue making significant technical progress toward license agreements with large semiconductor manufacturers. Despite some minor slowdowns due to the pandemic, we have strengthened our overall pipeline by adding a 17th customer engagement to the critical...

TUCSON, Ariz., Aug. 05, 2020 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will report its financial results for the second quarter ended June 30, 2020 after the market close on Tuesday, August 11, 2020. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time.About HTGHTG is focused on NGS-based molecular profiling. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG’s customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and...

Achieved Oxbryta® (voxelotor) net revenues of $31.5 million, with approximately 1,000 new patient prescriptions     Announced plans to seek approval of Oxbryta for younger pediatric patients in the United States and seek approval of Oxbryta in Europe Conference call today at 4:30 p.m. ETSOUTH SAN FRANCISCO, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today reported recent business progress and financial results for the second quarter ended June 30, 2020.“In the second quarter of 2020, we continued to make important progress on GBT’s vision of being a leading biopharmaceutical company and the leader in sickle cell disease. Despite the impact of COVID-19, we continued to successfully execute the launch of Oxbryta and make significant progress on new prescriptions, new prescribers, and...

SEATTLE, WA, Aug. 05, 2020 (GLOBE NEWSWIRE) — SAFR® from RealNetworks, Inc. (NASDAQ: RNWK), the leader in facial recognition and person-centric computer vision on live video, today announced it has been awarded two Phase II Small Business Innovation Research (SBIR) contracts of approximately $950k each or $1.9M in total from AFWERX. These contracts provide funding to adapt the SAFR platform for use by the Air Force for perimeter security and secure access. Once developed for the USAF, the SBIR/STTR program allows for any other federal agency to award a sole-source contract for technology developed under the program.Real-Time Facial Recognition for Perimeter Security and Force ProtectionIn partnership with Security Forces at a US Air Force base, SAFR will be enhanced to integrate real-time facial recognition across a range of fixed...

– Non-GAAP Net Income of $33.2 Million in the Second Quarter of 2020 –

MIAMI, Aug. 05, 2020 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) today announced that management will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on Monday, August 10, 2020 at 9:00 a.m. Eastern time.  In addition, management will be hosting one-on-one meetings with investors via organized conference calls.A live webcast of the fireside chat can be accessed from the investor section of OPKO’s website here. A replay of the event will be available for a period of time.About OPKO HealthOPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.Contacts:LHA...